KD

  • Bardoxolone methyl may reduce the stage of CKD

    Reata Pharmaceuticals and Abbott ’s phase 2b study suggests that bardoxolone methyl, an investigational treatment for chronic kidney disease (CKD), may reduce the stage of CKD and improve estimated glomerular filtration rate (eGFR) and other measu…

    KD | 04 February 2011

  • KD Scientific Offers Programmable Syringe Pumps

    The Legato 200 series of syringe pumps from KD Scientific offers ease of use through the high-resolution color touch screen user interface. The screen interface enables the user to quickly create configurations and recall them for easy use. The …

    KD | 01 January 2010

  • KDS Introduces Syringe Pump

    The KDS EZFlow 2020 is a durable syringe pump that is useful in high rate infusions. It is designed to enhance quick efficient operation while maintaining simplicity. The system has an automated calculation of delivery that is based on 4, 8, 12, …

    KD | 20 October 2009

  • Disposable Infusion Pump Minimizes Cross Contamination

    The KD Scientific EZFlow 2050 disposable infusion pump is designed to electronically deliver continuous, constantly controlled infusions and will meet the CE 0197 certification. Flow rates range from 2 to 10 ml/hr. The reservoir box comes in 100 m…

    KD | 10 August 2009

  • Genetic deficiency in children illuminates immune system breakdown

    Researchers have identified a genetic defect that makes these children susceptible to attack by a certain type of bacteria, a finding that will speed up the diagnosis and treatment of these sick children. The discovery is reported by Howard Hughe…

    KD | 31 July 2008